Lose Jennifer, Dorsch Michael P, DiDomenico Robert J
Hospital Pharmacy Services, Mayo Clinic Hospital - Rochester , Rochester, Minnesota.
Pharmacy Services and College of Pharmacy, University of Michigan Hospitals and Health Centers , Ann Arbor, Michigan.
Hosp Pharm. 2015 Jan;50(1):51-8. doi: 10.1310/hpj5001-51.
There is a paucity of data comparing practice patterns between board-certified specialists with added qualifications in cardiology (AQCV) and cardiovascular pharmacists without these credentials.
The purpose is to characterize differences in practice between inpatient pharmacists with and without AQCV.
We conducted a multicenter, retrospective, cross-sectional, case-controlled survey. An AQCV pharmacist list was extracted from the Board of Pharmacy Specialties Web site. Hospitals with AQCV pharmacists comprised the case group. Hospitals were excluded if the AQCV pharmacists did not provide direct patient care, practiced in the outpatient setting, or were in a Veterans Affairs hospital. Each case hospital was matched to hospitals without an AQCV pharmacist in a 1:3 ratio (case:control) by region, cardiovascular discharges, and teaching hospital status. Institutions completed a survey characterizing their pharmacy services.
Fifty-six hospitals completed the survey (21 AQCV, 35 non-AQCV). More AQCV pharmacists participated on rounds (100% vs 82.9%, P = .04) and devoted more time performing administrative tasks (20.5% ± 15.3% vs 11.1% ± 8.1%, P = .001) than non-AQCV pharmacists. Conversely, AQCV pharmacists spent less time providing clinical care (52.4% ± 14.5% vs 66.2% ± 19.8%, P = .007), were less involved with drug protocol management (71.4% vs 91.4%, P = .05), and performed less order verification than non-AQCV pharmacists.
Practice patterns differ between inpatient pharmacists with and without AQCV. Further research is needed to determine whether AQCV credentialing improves patient outcomes and to delineate what specific tasks performed by inpatient cardiology pharmacists may improve patient outcomes.
关于具有心脏病学附加资格的委员会认证专科医生(AQCV)与没有这些资质的心血管药剂师之间的实践模式比较,数据较少。
目的是描述有和没有AQCV的住院药剂师在实践中的差异。
我们进行了一项多中心、回顾性、横断面、病例对照调查。从药学专业委员会网站提取了一份AQCV药剂师名单。有AQCV药剂师的医院组成病例组。如果AQCV药剂师不提供直接的患者护理、在门诊环境中执业或在退伍军人事务医院工作,则将这些医院排除。每个病例医院按地区、心血管疾病出院人数和教学医院状况以1:3的比例(病例:对照)与没有AQCV药剂师的医院进行匹配。各机构完成了一项描述其药学服务的调查。
56家医院完成了调查(21家有AQCV,35家没有AQCV)。与没有AQCV的药剂师相比,更多的AQCV药剂师参与查房(100%对82.9%,P = 0.04),并且花费更多时间执行行政任务(20.5%±15.3%对11.1%±8.1%,P = 0.001)。相反,AQCV药剂师提供临床护理的时间较少(52.4%±14.5%对66.2%±19.8%,P = 0.007),参与药物方案管理的程度较低(71.4%对91.4%,P = 0.05),并且比没有AQCV的药剂师进行的医嘱核对更少。
有和没有AQCV的住院药剂师的实践模式不同。需要进一步研究以确定AQCV认证是否能改善患者预后,并确定住院心脏病学药剂师执行的哪些具体任务可能改善患者预后。